Then, PNA-PCR clamping and Sanger sequencing were used to blind test 90 DNA from 57 MDS and 33 MPN patients for the SF3B1 p.Lys700Glu mutation. This evidence concerns the gene SF3B1 and myeloproliferative neoplasm.